The Gujarat-based pharmaceutical company develops and manufactures medicines with a focus on women's healthcare, ...

Arun Kejriwal, Founder of Kejriwal Research and Investment Services, believes that the issue is expected to get benefit of ...

Corona Remedies Share Price, IPO Listing, GMP Live Updates: Corona Remedies is all set to hit the secondary market, after the ...

Listing gains, if any, are likely to be limited given the moderate subscription across investor categories, believe analysts.

After receiving 2.52 times oversubscription in its bidding rounds, the Wakefit Innovations public issue is set to hit Dalal ...

As per the latest update, the company’s shares are trading at Rs 1,353 in the unlisted markets. This indicates a premium of ...

The shares of Luxury Time made a bumper debut on stock markets on December 11, listing at Rs 155.80 per share on the BSE SME ...

Wakefit Solutions' shares are trading at a premium of ₹7 ahead of their listing on both BSE and NSE exchanges tomorrow, marking a significant milestone for the firm.

Wakefit’s listing marks an important step in its growth journey, as the company transitions from a privately held brand to a ...

As per latest reports from the unlisted market, shares of Park Medi World were trading at a premium of ₹7 per share. However, ...

Nephrocare Health IPO closes today, with a price band of ₹438–₹460. Investor sentiment is positive, GMP at ₹20 suggests a likely listing at ₹480. Day 2 subscription stood at 0.37x overall.

Dubai-based serial entrepreneur and venture capitalist Alexander Rugaev introduces boutique advisory focused on small-cap and ...